In vitro, ERα+ lines such as MCF-7 and ZR-75-1, which were derived from ERα+/luminal A tumours, retain a molecular profile characteristic of luminal A tumours, including low expression of ERBB2 [8]; they also display poor invasive and metastatic ability [3,8,9]. This evidence concerns the gene ERBB2 and neoplasm.